RADIANT4_2A: RADIANT4, figure 2A

RADIANT4_2AR Documentation

RADIANT4, figure 2A

Description

Kaplan-Meier digitized data from RADIANT4, figure 2A (PMID 26703889). A reported sample size of 302 for a primary endpoint of PFS in lung/colorectal cancer.

Usage

RADIANT4_2A

Format

A data frame of 302 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (everolimus, placebo)

Source

Yao JC, Fazio N, Singh S, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet 2016; 387: 968–77.

Examples

summary(RADIANT4_2A)

kmplot(RADIANT4_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.